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Background: Hepatitis C virus (HCV) is a hepatotropic, blood-borne virus, but in up to
one-third of infections of the transmission route remained unidentified. Viral genome
copies of HCV have been identified in several body fluids, however, non-parental
transmission upon exposure to contaminated body fluids seems to be rare. Several body
fluids, e.g., tears and saliva, are renowned for their antimicrobial and antiviral properties,
nevertheless, HCV stability has never been systematically analyzed in those fluids.
Methods: We used state of the art infectious HCV cell culture techniques to investigate
the stability of HCV in different body fluids to estimate the potential risk of transmission
via patient body fluid material. In addition, we mimicked a potential contamination
of HCV in tear fluid and analyzed which impact commercially available contact lens
solutions might have in such a scenario.
Results: We could demonstrate that HCV remains infectious over several days in body
fluids like tears, saliva, semen, and cerebrospinal fluid. Only hydrogen-peroxide contact
lens solutions were able to efficiently inactivate HCV in a suspension test.
Conclusion: These results indicate that HCV, once it is present in various body fluids
of infected patients, remains infective and could potentially contribute to transmission
upon direct contact.
Keywords: hepatitis C virus, infectivity, saliva, semen, tear, contact lens solution, cerebrospinal fluid
Abbreviations: CSF, cerebrospinal fluid; DAA, direct acting antiviral drugs; HBV, hepatitis B virus; HCV, hepatitis C virus;
HIV, human immunodeficiency virus; JFH, Japanese fulminant hepatitis; MSM, men who have sex with men; PWIDs, people
who inject drugs; qRT-PCR, quantitative real time-polymerase chain reaction; SD, standard deviation; TCID50, tissue culture
infectious dose 50.
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INTRODUCTION
Chronic HCV infection affects more than 71 million people
worldwide and can lead to liver diseases like chronic hepatitis,
cirrhosis, and hepatocellular carcinoma (Manns et al., 2017).
One hallmark of HCV is its high degree of sequence variability
which likely contributes to its ability to establish chronic
infections. Different patient isolates are grouped into seven
genotypes and more than 100 subtypes within the genus
Hepaciviridae of the family Flaviviridae (Smith et al., 2014).
While several potent DAAs have reached the market in the
recent years, there is still no vaccine against HCV available
(Tarr et al., 2015). Therefore, health care workers and other
individuals like PWIDs or dialysis patients are at constant
risk to acquire an HCV infection due to cross-transmission
and accidental or occupational exposure. While it is well
established that direct blood contact with infected individuals
may cause an acute HCV infection, other transmission routes
are uncertain and in up to one-third of HCV infected
patients the cause of infection remained unclear (Ponde,
2011).
Several mechanical, chemical, and/or biological barriers
protect humans from viral or bacterial infection. For example,
the flushing action of tears and urine mechanically expels
pathogens, while enzymes such as lysozyme and phospholipase
A2 in saliva, tears, and breast milk can exert antimicrobial
properties (Stiehm and Keller, 2001; Malamud et al., 2011;
McDermott, 2013). Several studies have reported that HCV
RNA can be detected in different human body fluids of HCV-
infected patients such as saliva, semen, urine, sweat, and tears
(Numata et al., 1993; Mendel et al., 1997; Leruez-Ville et al.,
2000; Bourlet et al., 2002; Ortiz-Movilla et al., 2002; Suzuki
et al., 2005; Wang et al., 2006). However, only serum has been
demonstrated to be infectious in humans or experimental animal
models (Billerbeck et al., 2013; Pfaender et al., 2016) and the
infection risk associated with various human body fluids is not
well defined. A reason for this ambiguity in transmission risks
is that infection experiments with primary HCV material are
technically not possible and cell culture assays permissive to HCV
infection have not been available for a long time (Steinmann
and Pietschmann, 2013). This obstacle has been overcome with
the development of an HCV cell culture system based on the
JFH HCV isolate (Wakita et al., 2005) and in fact different
studies have recently assessed the stability of HCV and its
susceptibility to different biocides using this system (Ciesek
et al., 2010; Doerrbecker et al., 2011, 2013). Further, we could
recently show that human breast milk exerts an antiviral effect
against HCV due to endogenous lipase-dependent generation
of free fatty acids, which destroys the viral lipid envelope of
HCV (Pfaender et al., 2013). However, the anti- or pro-viral
effects of other human body fluids have not been investigated
so far.
In this study, we investigated the environmental stability
of HCV in saliva, semen, CSF, and tears, the later in
combination with contact lens solutions, to elucidate potential
transmission risks or inactivation properties of these human body
fluids.
MATERIALS AND METHODS
Cell Culture and Reagents
For HCV infection experiments a human hepatoma cell
line, designated Huh7.5, was used which is permissive
for HCV infection and replication (Steinmann et al.,
2008). The cells were grown in Dulbecco’s Modified
Eagle Medium (DMEM; Invitrogen, Karlsruhe, Germany)
supplemented with 2 mM L-glutamine, non-essential
amino acids, 100 U of penicillin per mL, 100 µg of
streptomycin per mL, and 10% fetal calf serum (DMEM
complete).
Plasmids and in Vitro Transcription
The plasmid pFK-Jc1 has been described recently and encodes
the intragenotypic 2a/2a chimeric virus Jc1 (Pietschmann et al.,
2006). In vitro transcripts of the individual constructs were
generated by linearizing 5–10 µg of the Jc1 plasmid by
digestion for 1 h with Mlu I. Plasmid DNA was extracted with
phenol and chloroform and after precipitation with ethanol
dissolved in RNase-free water. In vitro transcription reaction
mixtures contained 80 mM HEPES (pH 7.5), 12 mM MgCl2,
2 mM spermidine, 40 mM dithiothreitol (DTT), a 3.125 mM
concentration of each ribonucleoside triphosphate, 1 U of
RNasin (Promega, Mannheim, Germany) per µL, 0.1 µg plasmid
DNA/µL and 0.6 U of T7 RNA polymerase (Promega) per µL.
After incubation for 2 h at 37◦C, an additional 0.3 U of T7 RNA
polymerase/µL reaction mixture was added, followed by another
2 h at 37◦C. Transcription was terminated by the addition of
1.2 U of RNase-free DNase (Promega) per µg of plasmid DNA
and 30 min incubation at 37◦C. The RNA was extracted with
acidic phenol and chloroform, precipitated with isopropanol
and dissolved in RNase-free water. The concentration was
determined by measurement of the optical density at 260 nm.
Denaturing agarose gel electrophoresis was used to check RNA
integrity.
Electroporation of Viral RNA and
Production of Cell Culture-Derived HCV
For electroporation of HCV RNA into Huh7.5 cells, single-cell
suspensions were prepared by trypsinization of monolayers and
subsequent resuspension with DMEM complete. Huh7.5 cells
were washed with phosphate-buffered saline (PBS), counted and
resuspended at 1.5 × 107 cells per mL in cytomix containing
2 mM ATP and 5 mM glutathione. Unless otherwise stated,
10 µg of in vitro transcribed RNA was mixed with 400 µL
cell suspension by pipetting and then electroporated with a
Gene Pulser system (Bio-Rad, Munich, Germany) in a cuvette
with a gap width of 0.4 cm (Bio-Rad) at 975 µF and 270 V.
Cells were immediately transferred to 16 mL complete DMEM
and 8 mL of the cell suspension was seeded per well. Virus-
containing culture fluids were harvested after 48, 72, and
96 h and concentrated using centricons (Centricon plus-70,
Millipore, United States). For determination of viral infectivity
cell-free supernatants were used to infect naive Huh7.5 target
cells.
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Immunohistochemical Staining and Virus
Titration
Virus titers were determined as described elsewhere (Ciesek et al.,
2011). In brief, Huh7.5 cells were seeded in 96-well plates at
a density of 1 × 104 cells per well 24 h prior to inoculation
with dilutions of filtered cell culture supernatant (at least six
wells were used per dilution). Two to three days later, cells were
washed with PBS, fixed for 20 min with ice-cold methanol at
−20◦C, washed three times with PBS and then permeabilized
and blocked for 1 h with PBS containing 0.5% saponin, 1%
bovine serum albumin, 0.2% dried skim milk, and 0.02% sodium
acid. Endogenous peroxidases were blocked by incubating cells
for 5 min with PBS containing 0.3% hydrogen peroxide. After
three times washing with PBS and once with PBS containing
0.5% saponin (PBS – saponin), NS5A was detected with a 1:1,000
dilution of hybridoma supernatant 9E10 in PBS – saponin for
1 h at RT or overnight at 4◦C. Cells were washed as described
above, and bound 9E10 antibody was detected by incubation
with peroxidase – conjugated antibodies specific to murine IgG
(Sigma-Aldrich, Steinheim, Germany) diluted 1:200 in PBS –
saponin. After 1 h incubation at RT cells were washed as specified
above. Finally, peroxidase activity was detected by using the
Vector NovaRED substrate kit (Linaris, Wertheim, Germany)
and TCID50 was determined.
Testing of HCV Stability in Different Body
Liquids
To test if HCV stability changes in different body liquids, virus
diluted in tears (1:8), CSF (1:9), semen (1:9), or saliva (1:9) were
incubated at room temperature for the respective time period.
Effect of body liquid on HCV stability was compared to a virus
suspension containing the respective amount of PBS. After the
incubation period, target cells were infected in a limiting dilution
assay on Huh7.5 cells. The TCID50 was determined 72 h post
infection as described before (Steinmann et al., 2008).
Virucidal Activity of Contact Lens
Solutions
The virucidal activity testing of eight different contact lens
solutions (Table 1) was carried out by mixing two part of test
virus suspension with eight parts of the respective contact lens
solutions in analogy to a virus suspension test described before
(Ciesek et al., 2010). After different incubation times, the test
mixtures were immediately serially diluted in DMEM and virus
titers determined by TCID50. To analyze the effect of tear fluids
on the virucidal activity of contact lens solutions, one part of test
virus suspension, one part tear fluid and eight parts of contact
lens solutions were mixed and tested as described above.
Statistics
For statistical analyses either one-way ANOVA followed by
Dunnett’s multiple comparisons test or two-way ANOVA
followed by Sidak’s multiple comparisons test was performed
using GraphPad Prism version 7.03 for Windows, GraphPad
Software, La Jolla, CA, United States, www.graphpad.com.
TABLE 1 | Contact lens solutions employed in this study and their active
ingredients.
Trade name Manufacturer Active ingredients
AOSept R© Plus CIBA Vision 3.0% hydrogen peroxide
OPTI-FREE R© ever
moist
Alcon 0.001% polyquaternium-1
0.0006% myristamidopropyl
dimethylamine
iWear All-in-1 Basic Sauflon –
Boston Simplus Bausch and Lomb Poloxamine
COMPLETE R©
Multi-Purpose
Solution
Abbott 0.0001% polyhexamethylene
biguanide 0.05% poloxamer
237 0.02% edetate disodium
Total Care Abbott 0.0005% polyhexamethylene
biguanide 0.01% edetate
disodium
Best View
All-in-One
ROSSMANN 0.0001% polyhexamethylene
biguanide 0.01% edetate
disodium
Oculsoft R© comfort Bausch and Lomb 0.0005% polyaminopropyl
biguanide 0.003%
chlorhexidine gluconate 0.05%
edetate disodium
Ethical Aspects
All body fluids were obtained from anti-HCV and HCV RNA
negative healthy volunteers. The CSF samples were used after
performing a conventional microbiological diagnosis. The study
did not include patient’s details and did not result in additional
constraints for the patients. All data were anonymously analyzed.
The study had been approved by the ethics committee of
Hannover Medical School, Germany.
RESULTS
Infectious HCV Can Persist in Saliva for a
Prolonged Time
Saliva is well described for its antimicrobial effects due to different
enzymes (Malamud et al., 2011). Nevertheless, several human
viruses can be efficiently transmitted by saliva by direct transfer
from infected individuals to non-infected persons (Ross, 1971).
HCV RNA has been detected in saliva of infected patients (Suzuki
et al., 2005; Wang et al., 2006), however, its infective potential
has not been analyzed so far. To evaluate HCV stability in saliva
and the influence of potential defense mechanisms present within
this body fluid, HCV and saliva were incubated in suspension
for selected time points up to 28 days at room temperature. As
control, virus was incubated with PBS. To take donor variations
into account, saliva samples from five individual donors were
used. Infectivity was determined by limiting dilution assay. HCV
infectivity was detectable up to 21 days at room temperature in
all samples, with minor difference between saliva and control
incubated samples (Figure 1). For one donor, even higher viral
titers could be observed compared to the control incubation.
The overall infectivity decreased in a time-dependent manner,
however, no antiviral effect of saliva on HCV infectivity could be
observed. Four weeks post inoculation, HCV infectivity dropped
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FIGURE 1 | Stability of HCV in human saliva. One part of virus was added to
one part of saliva and incubated for 7, 14, 21, or 28 days at room
temperature. The saliva samples of five individual donors were used (black
circles). Saliva was filtered (0.45 µm) and stored at 4◦C before testing. In the
untreated control the saliva was replaced with PBS (open circles). After
incubation, mixtures were stored at –80◦C until viral titers were determined by
a limiting dilution assay to calculate the tissue culture infection dose
(TCID50/mL). Data were normalized to the infection at time point zero of each
experiment. Dashed line indicates assay background, n.s., not significant.
below the detection limit in only two out of five donor samples
(Figure 1). In conclusion, HCV is stable in saliva for up to 3 weeks
at room temperature and remains its infective potential.
Semen Does Not Enhance or Abrogate
HCV Infectivity
Hepatitis C virus can be transmitted through sexual intercourse.
Terrault et al. (2013) found that the maximum incidence rate of
HCV transmission by sex was 0.07% per year, which is lower
compared to other sexually transmitted diseases like HIV or
herpes simplex virus type 2 (HSV-2). Especially for HIV, it has
been described that semen enhances HIV infectivity (Münch
et al., 2007), thereby facilitating viral transmission. We next
investigated the influence of semen on HCV infectivity. To this
end, we collected semen from healthy volunteers and incubated it
together with HCV in suspension for 24 h at room temperature.
Infectivity was determined by a limiting dilution assay after 72 h.
In total, a pool of 30 different semen samples, encompassing
semen samples from 10 individual donors were used. As shown
in Figure 2, none of the tested semen samples enhanced or
abrogated HCV infectivity under these experimental conditions
(Figure 2). These results indicate that potential infectious virus
present in semen remains stable and infectivity seems not to be
influenced by seminal fluid.
Cerebrospinal Fluid Has No Pro- or
Antiviral Effects on HCV
Even though HCV exhibits a liver tropism, extrahepatic
manifestations have been described (Negro et al., 2015). It is still
a long debate if HCV infects the brain, however, up to 20–80% of
patients with chronic HCV exhibit symptoms like chronic fatigue
FIGURE 2 | Stability of HCV in human semen. One part of virus was added to
nine parts of semen and incubated for 24 h at room temperature. A pool of 30
different semen samples and semen samples from nine individual donors were
used (black circles). In the untreated control the sperm was replaced with PBS
(open circles). Viral titers were determined by a limiting dilution assay to
calculate the tissue culture infection dose (TCID50/mL), n.s., not significant.
(Yarlott et al., 2017). In addition, there are several reports of
deficits in attention, concentration, and memory or depression
(Yarlott et al., 2017). Furthermore, HCV RNA has been detected
in CSF and the brain of chronically infected patients with
neuropathological abnormalities (Maggi et al., 1999; Laskus et al.,
2002; Vargas et al., 2002). Fletcher et al. (2012) have shown that
brain microvascular endothelial cells (BMECs), are permissive
to HCV infection in culture, however, if CSF itself might have
pro- or antiviral effects is unknown. To address this question,
we tested HCV infectivity in CSF of eight different individuals
by incubation for selected time points at room temperature.
As control, virus was incubated with PBS in suspension. We
monitored viral stability in CSF for up to 21 days, and could
not detect any pro- or antiviral effects on HCV (Figure 3). The
virus remained infectious upon the time course. This indicates
that virus which potentially crosses the blood–brain barrier and
enters the CSF retains its infectious capacity for several weeks.
Tears Do Not Decrease HCV Infectivity
but Can Abrogate the Antiviral Effects of
a Contact Lens Solution
Tear fluid from chronically HCV infected patients has been
shown to contain viral genome copies as determined via qRT-
PCR (Feucht et al., 1994; Mendel et al., 1997; Komatsu et al.,
2012). However, there are no indications that HCV can be
transmitted via tears. It is known, that tear fluid contains several
antiviral and antimicrobial components (Chandler and Gillette,
1983). To investigate if tear fluid can potentially inactivate HCV,
tear fluid of a healthy volunteer and virus suspension were
incubated for selected time points at room temperature. As
shown in Figure 4A, we were not able to detect any effect on HCV
infectivity 5 min and 20 h after incubation with tears indicating
that potential antimicrobial factors present in tear fluid are not
able to inactivate HCV sufficiently (Figure 4A).
Given the well documented presence of HCV RNA in
tears, we next wanted to evaluate the effects of contact lens
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FIGURE 3 | Effect of CSF on HCV. One part of virus was added to nine parts
of CSF and incubated for 7, 14, 21, or 28 days at room temperature. The CSF
samples from eight individual donors were used (black circles). In the
untreated control the liquor is replaced with PBS (open circles). Samples were
stored at –80◦C until viral titers were determined by a limiting dilution assay to
calculate the tissue culture infection dose (TCID50/mL). Data were normalized
to the infection at time point zero of each experiment. Dashed line indicates
assay background, n.s., not significant.
solutions on viral stability. To this end, we chose eight different
commercially available contact lens solutions for cleaning
and storage of contact lenses (Table 1). The contact lens
solutions were based on different ingredients like hydrogen
peroxide, polyquaternium, myristamidopropyl dimethylamine,
and polyhexanide. To analyze viral stability, one part of HCV
was added to nine parts of the selected contact lens cleaning
solution and incubated for designated time points at room
temperature. Only one solution (AOSept R© Plus; “AO sept”),
which is based on hydrogen peroxide was able to inactivate
HCV infectivity quite rapidly and completely, whereas the other
solutions demonstrated low antiviral activity or were able to
reduce viral titers only after a prolonged incubation time of
20 h (Figure 4B). We chose one contact lens solution, namely
“Oculsoft comfort,” which was able to efficiently reduce viral titers
after a prolonged incubation period of 20 h, to mimic a more
physiological situation, and to investigate if the antiviral effect
was influenced due to the presence of tear fluid. Therefore, we
incubated for 5 min and 20 h solution “Oculsoft comfort” with
tear fluid and virus suspension and determined viral titers by
a limiting dilution assay. Interestingly, in the presence of tear
fluid the inhibitory effect on HCV infectivity of the contact lens
solution was abrogated (Figure 4C). In conclusion, we could
show that HCV infectivity remains stable in tear fluid and that
commercially available contact lens solutions are rarely sufficient
to inactivate a potentially contaminated lens.
DISCUSSION
Several viruses are known to be transmitted via saliva,
with the classical example being Epstein–Barr virus-induced
mononucleosis, which is broadly known as kissing disease
FIGURE 4 | Effect of tear fluid and contact lens cleaning solutions on HCV. (A) Eight parts of medium were incubated with one part of tear fluid and on part of virus
suspension for 5 min (black bars) or 20 h (gray bars) at room temperature. For the untreated control PBS was used. Viral titers were determined by a limiting dilution
assay to calculate the tissue culture infection dose (TCID50/mL). (B) One part of virus was added to nine parts of the selected contact lens cleaning solution and
incubated for 5 min (black bars) or 20 h (gray bars) at room temperature. For the untreated control PBS was used. Viral titers were determined by a limiting dilution
assay to calculate the tissue culture infection dose (TCID50/mL). n.d., not detected above toxicity background, ∗∗∗p ≤ 0.001. (C) Eight parts of contact lens solution
Oculsoft comfort were incubated with one part of tear fluid and on part of virus suspension for 5 min (black bars) or 20 h (gray bars). For the untreated control PBS
was used. Tear fluid was replaced in the control with PBS. Viral titers were determined by a limiting dilution assay to calculate the tissue culture infection dose
(TCID50/mL).
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(Niederman et al., 1970). There are several studies that describe
the presence of HCV RNA in the saliva of about 39–72% of
chronically infected patients (Ferreiro et al., 2005). However,
most epidemiological studies suggest that HCV transmission
via contaminated saliva is low and there is no evidence that
HCV can easily be spread via salivary exchange, e.g., upon
kissing, sneezing, coughing, etc. (Ferreiro et al., 2005). There
seems to be a correlation between the presence of virus in
saliva and the viral load in blood, however, viral levels in
saliva are in general low compared to blood levels (Wang
et al., 1992; Numata et al., 1993). It is not known whether
there are specific defense mechanisms, e.g., due to the presence
of neutralizing antibodies or non-specific defense mechanisms,
like antiviral enzymes, that contribute to this observed low
transmission route. To analyze potential antiviral mechanisms
in the saliva of healthy individuals, we tested HCV stability
over a prolonged time. HCV infectivity was surprisingly not
altered when incubated with saliva and remained stable for
up to 1 month. It is possible that the observed low level of
virus present in saliva is not sufficient to mediate an efficient
transmission; however, the potential risk should not be neglected,
especially upon scenarios where the natural barrier has been
disrupted.
While HIV is mainly transmitted via sexual intercourse,
transmission risk for HCV via this route seems to be rather low
and is associated with specific risk groups like MSM (Butler et al.,
2010). While semen derived fibrils have been demonstrated to
enhance HIV infectivity (Münch et al., 2007), the influence of
seminal fluid on HCV stability is not clear. We therefore aimed
to analyze viral infectivity in the semen from healthy donors.
Unlike HIV, we could demonstrate that HCV infectivity was not
affected by semen, as it neither abrogated nor enhanced viral
infectivity, suggesting that seminal amyloid does also not affect
HCV infectivity.
Several HCV patients experience significant changes in their
physical and mental well-being, which are most commonly
manifested as fatigue and depression. Indeed, the brain has
been proposed as an extrahepatic replication site for HCV with
endothelial cells from the blood–brain barrier and peripheral
neuroblastoma cells being able to support HCV infection (Burgel
et al., 2011; Fletcher et al., 2012). Laskus et al. (2002) were
able to show that around 60% of all patients with chronic
HCV had detectable HCV RNA levels in the CSF. A recent
study even revealed genetic compartmentalization in the CSF
from cogitative impaired patients supporting the theory for an
extrahepatic manifestation (Tully et al., 2016). CSF contains
>99% water, low amounts of plasma proteins and glucose
and sporadic lymphocytes (Spector et al., 2015). Antimicrobial
properties are not described, but the low amounts of proteins
and glucose might lead to a reduced stability of viruses in CSF.
We here show that HCV incubated in CSF is as stable as HCV
incubated in PBS. We could confirm that CSF has no antiviral
activity against HCV and that HCV can survive in CSF for a
longer period of time.
Next to the other body fluids, HCV RNA has been
readily detected in the tear fluid of HCV-infected patients
(Feucht et al., 1994; Mendel et al., 1997). Also for other viruses
like HIV, HBV, or Ebola Virus tears have been described as viral
positive body fluid (Su et al., 1994; Han et al., 2011; Vetter
et al., 2016). Importantly, HBV isolated from tears of chronically
infected patients has even been shown to be infectious in the
animal model (Komatsu et al., 2012), emphasizing a possible
viral transmission risk via tear fluid. Nevertheless, tear-mediated
transmission of HCV has not been described so far. Tears
are known to contain a number of antimicrobial components
which help to protect the eye from infection (Flanagan and
Willcox, 2009). One prominent component is lactoferrin which
has been described for its antimicrobial and anti-inflammatory
properties (Flanagan and Willcox, 2009). To investigate whether
HCV is able to retain its infectivity within tear fluid, we
analyzed its stability upon artificial contamination with HCV
and could observe no decrease in viral titer. This indicates
that possible antiviral components described to be present
in tear fluid, like lactoferrin, are not sufficient to inactivate
HCV. Next, we tested additionally if commercially available
contact lens solutions were able to inactive a potential HCV
contamination. Surprisingly, solutions which are not based on
hydrogen peroxide were not able to readily inactivate HCV.
Only two other solutions were able to reduce viral titers by
several orders of magnitude after 20 h incubation. Even more
important, the antiviral effect of one contact lens solution became
abrogated in the presence of tear fluid. A phenomenon that
has been also observed for different bacteria (Hildebrandt et al.,
2012). These results show for the first time that several body
fluids do not exert antiviral activities against HCV. However, to
determine if they could be a possible source of HCV transmission
in the environment, in vivo experiments with, e.g., humanized
mice would be necessary. HCV RNA has also been detected
in human sweat of HCV-positive patients (Ortiz-Movilla et al.,
2002) as well as urine (Numata et al., 1993), however, both
body fluids were not included in the present study for further
analysis.
In summary, we present the first systematic investigation
of HCV stability and infectivity in different body fluids.
Even though transmission via saliva, tears, semen, or other
non-parental body fluids are believed to be rare, we could
clearly demonstrate that virus remains infective within these
fluids and could potentially become transmitted. It is likely
that the reduced viral loads in the diverse body fluids,
as compared to viral levels in blood, are responsible for
the observed low transmission rates, however, transmission
might still be possible and its risk should not be fully
neglected. In conclusion, strict compliance to established
hygienic guidelines should be mandatory to avoid further HCV
infections.
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